Skip to main content
Jeremiah Brown Jr., MD, Ophthalmology, Schertz, TX

JeremiahBrownJr.MDM.S.

Ophthalmology Schertz, TX

Retinal Disease, Uveitis

Brown Retina Institute

Dr. Brown is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Brown's full profile

Already have an account?

  • Office

    17319 Interstate 35 N
    Ste 303
    Schertz, TX 78154
    Phone+1 210-693-1063
    Fax+1 830-214-2718

Education & Training

  • U Iowa Hosps and Clinics
    U Iowa Hosps and Clinics1998
  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Ophthalmology, 1996
  • Hartford Hospital
    Hartford Hospital1991 - 1992
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1991
  • Univ of California, Berkeley
    Univ of California, BerkeleyM.S., Health Policy, 1986 - 1989
  • Harvard College
    Harvard CollegeB.A., Biology, 1981 - 1985

Certifications & Licensure

  • IA State Medical License
    IA State Medical License 1992 - 2025
  • TX State Medical License
    TX State Medical License 2000 - 2025
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow ASRS American society of Retina Specialists, 2020
  • Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • AMD, DME Therapies Aimed at Reducing Treatment Burden Shine at AAO 2024
    AMD, DME Therapies Aimed at Reducing Treatment Burden Shine at AAO 2024November 1st, 2024
  • Diabetic Eye Disease Worst in Hispanic and Latino Patients, but Treatment Response More Robust
    Diabetic Eye Disease Worst in Hispanic and Latino Patients, but Treatment Response More RobustOctober 22nd, 2024
  • Genentech’s Vabysmo Improved Vision in Underrepresented Populations with Diabetic Macular Edema (DME) in a First-of-Its-Kind Study
    Genentech’s Vabysmo Improved Vision in Underrepresented Populations with Diabetic Macular Edema (DME) in a First-of-Its-Kind StudyOctober 18th, 2024
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish